Connection

Kathleen Brady to Cannabinoids

Back to Details
This is a "connection" page, showing publications Kathleen Brady has written about Cannabinoids.
Kathleen Brady
Connection Strength
0.293
Cannabinoids
  1. A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents. Am J Psychiatry. 2012 Aug; 169(8):805-12.
    View in: PubMed
    Score: 0.092
  2. A placebo-controlled trial of buspirone for the treatment of marijuana dependence. Drug Alcohol Depend. 2009 Nov 01; 105(1-2):132-8.
    View in: PubMed
    Score: 0.075
  3. Buspirone for treatment of marijuana dependence: a pilot study. Am J Addict. 2006 Sep-Oct; 15(5):404.
    View in: PubMed
    Score: 0.061
  4. The effects of delta 9-tetrahydrocannabinol alone and in combination with cannabidiol on fixed-interval performance in rhesus monkeys. Psychopharmacology (Berl). 1980; 72(1):21-6.
    View in: PubMed
    Score: 0.038
  5. Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial. Drug Alcohol Depend. 2015 Nov 01; 156:29-37.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.